Patterns of mortality in sickle cell disease in the United Kingdom.
about
Gene therapy for sickle cell diseaseInhaled bronchodilators for acute chest syndrome in people with sickle cell diseaseInhaled bronchodilators for acute chest syndrome in people with sickle cell diseaseGene therapy for sickle cell diseaseGene therapy for sickle cell diseaseAdenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.Acute chest syndrome: sickle cell disease.Hydroxyurea for sickle cell disease.Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research.Gene therapy for sickle cell disease.The comprehensiveness care of sickle cell disease.Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome.Bone marrow transplant for sickle cell disease--an updateManagement of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).The role of rib infarcts in the acute chest syndrome of sickle cell diseases.Clinical presentation of acute chest syndrome in sickle cell disease.Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activationOutcome and challenges of kidney transplant in patients with sickle cell disease.Clinical correlates of acute pulmonary events in children and adolescents with sickle cell diseaseSickle cell anemia-associated pulmonary arterial hypertension.Complications of sickle cell anaemia in children in Northwestern Tanzania.Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes.Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.Differences in the clinical and genotypic presentation of sickle cell disease around the world.Improving outcomes in children with sickle cell disease: treatment considerations and strategies.Mobile Right Atrial Thrombi in a Patient with the Hemoglobin SC Disease.Hydroxyurea (hydroxycarbamide) for sickle cell disease.Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.Mortality, asthma, smoking and acute chest syndrome in young adults with sickle cell disease.Sickle cell disease: the case for coordinated information.Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group.A two-event in vitro model of acute chest syndrome: the role of secretory phospholipase A2 and neutrophils.Pulmonary artery thrombosis: another piece to the acute chest syndrome puzzle.The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania
P2860
Q24193117-CEBC9346-F26E-412A-86AE-748882D43CFDQ24194510-491F7CAB-A3E0-4DC6-BD7A-58BE8EEF8446Q24202109-D44A7250-13C5-4C18-8D75-35D21985A79CQ24202911-78D6585D-C0D6-412F-965B-DBCCB243F95EQ24236524-BC1F8BAE-33F0-4DA2-AC42-1369B96F65E6Q30429393-2E5EE244-459D-4C36-A599-8A0025B534E3Q30435470-F5608EB8-6534-49B1-A3A8-0A71C2949C4FQ34187526-DEABD6E7-BB7B-4E2A-AD80-8C4C9A2B8C13Q34281892-5CBBFD24-269E-491F-80C2-DA58ADBF6EC5Q34460805-38F75F40-8FEA-40A0-AB09-2F33EB6AE0D8Q34544622-1790D2E8-C0DC-4588-A77F-278316273169Q34689854-97FD9FD4-6938-4994-A884-053153B57CB8Q34782494-1363E8E4-923A-45F5-8E1B-7B4ECA576177Q34799417-441F2ED1-19A8-47B8-BC6E-43E1DAB12F45Q35034032-B935AA39-3E1A-4F28-B845-5B4CD9BF6DFEQ35098076-1A10616E-C690-4183-8FFA-E863A5A4AFF3Q35519587-8112138E-6FE8-42FD-9982-1D8AA779BF02Q36022938-FE1E6C93-16E9-4B73-AA48-51D525616F0EQ36120377-A59EEDC6-150A-4C0F-A48C-EA1D19445984Q36830328-B9515EE5-DD08-4A11-9A70-34D6EFF6E1F6Q36947395-5E1D1CC5-A8B6-44AE-B185-47A72F1F6167Q37008399-B6E843CC-6EFE-45CF-8D67-89305EE3CB53Q37149765-99EFDCC9-7760-4D07-AE73-C1E5B0F6DA24Q37318962-E1323D40-DA36-4E66-A1D6-A19E462CC255Q37398351-3492CA21-FF89-46A6-875B-ADF1D300B560Q37620798-FE76325F-444E-4030-B239-2569861B1F39Q38209472-F7062A40-8F8F-4411-8515-9162ED0929CDQ38333866-7B915F8E-28A6-4706-B887-846836AAB08EQ38692796-92B55B94-BF96-40A8-9064-484871BDE5A7Q38817266-EC4AD295-4FD8-4651-8D1C-A27D7B324AE5Q39141859-FB0A9D66-EC5C-4696-9D72-7586053405F3Q43153263-E229A5AB-F905-405A-8B68-4BBEE6DA5D2BQ46151410-4BA1C4FD-5988-4BCA-9248-C793ED6B0735Q50528719-14EE8F3A-D52F-457E-A124-B06893CE7FFEQ53193712-1A09C9B0-5661-4241-8FD4-E95432BC3E29Q58732496-5D5645CF-59E4-42F4-B141-238E942E971F
P2860
Patterns of mortality in sickle cell disease in the United Kingdom.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patterns of mortality in sickle cell disease in the United Kingdom.
@en
Patterns of mortality in sickle cell disease in the United Kingdom.
@nl
type
label
Patterns of mortality in sickle cell disease in the United Kingdom.
@en
Patterns of mortality in sickle cell disease in the United Kingdom.
@nl
prefLabel
Patterns of mortality in sickle cell disease in the United Kingdom.
@en
Patterns of mortality in sickle cell disease in the United Kingdom.
@nl
P2093
P2860
P356
P1476
Patterns of mortality in sickle cell disease in the United Kingdom.
@en
P2093
P2860
P304
P356
10.1136/JCP.44.6.459
P407
P577
1991-06-01T00:00:00Z